Aquestive Therapeutics Financial Overview
Aquestive Therapeutics's market cap is currently $707.62M. The company's EPS TTM is $-0.14; its P/E ratio is -8.25; Aquestive Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
